| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director, 10% Owner | Director
9 companies
Armistice Capital, LLC serves as a 10% Owner at HIND and has filed Form 4s across 9 companies. Across recent SEC filings that breaks down to 337 buys and 114 sells. Those positions are worth an estimated $10.1M at current prices.
Historically, Armistice Capital, LLC's trades have earned a middling insider score of 56/100 across 42 rated trades. Over a 12-month horizon, 23.8% of those trades were profitable, with an average 12-month return of -33.4%.
The biggest single holding is ACHV (~$3.7M) as 10% Owner. The recent filings there lean toward selling, a net 299,332 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 11,000 | $2.50 | $27,527.48 | +1.6% | |
| Mar 19, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 1,981,219 | $2.05 | $4,058,380.18 | -155.2% | |
| Mar 10, 2020 | AYTU Aytu Biopharma, Inc | Director | Sale+OE | 22,026,801 | $1.42 | $31,200,122.91 | -100.0% | |
| Feb 10, 2020 | KPRX Kiora Pharmaceuticals Inc | Director, 10% Owner | Buy | 23,000 | $6.11 | $140,460.00 | +1.3% | |
| Feb 3, 2020 | AVTX Avalo Therapeutics, Inc. | Director, 10% Owner | Buy | 1,256,282 | $3.98 | $5,000,002.36 | -216.1% | |
| Dec 20, 2019 | AYTU Aytu Biopharma, Inc | Director, 10% Owner | Buy | 78,788 | $0.86 | $67,749.80 | +1.0% | |
| Nov 7, 2019 | VXRT Vaxart, Inc. | Director, 10% Owner | Buy | 200,000 | $0.34 | $67,256.18 | +0.8% | |
| Oct 7, 2019 | VXRT Vaxart, Inc. | 10% Owner | Buy | 564,000 | $0.36 | $203,200.00 | +2.3% | |
| Oct 3, 2019 | VXRT Vaxart, Inc. | 10% Owner | Buy | 436,000 | $0.35 | $150,551.93 | +1.8% | |
| Sep 30, 2019 | KPRX Kiora Pharmaceuticals Inc | Director, 10% Owner | Buy | 605,001 | $3.12 | $1,890,613.11 | +50.9% |